Mankind Pharma Limited (MANKIND.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 827.82B |
| Enterprise Value | 886.11B |
| P/E Ratio | 48.96 |
| PEG Ratio | 1.81 |
| Price/Sales Ratio | 7.14 |
| Price/Book Ratio | 6.25 |
| Enterprise/Revenue | 7.42 |
| Enterprise/EBITDA | 26.62 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.15 |
| Operating Margin | 0.21 |
| Return On Assets | 0.08 |
| Return On Equity | 0.14 |
| Revenue | 142.78B |
| Revenue/Share | 372.42 |
| Gross Profit | 61.55B |
| EBITDA | 38.58B |
| Net Income | 19.13B |
| Diluted EPS | 46.28 |
| Total Cash | 26.6B |
| Total Cash/Share | 64.42 |
| Total Debt | 54.22B |
| Total Debt/Equity | 0.31 |
| Current Ratio | 1.35 |
| Book Value Per Share | 432.4 |
| 52-Week Change | 19.79 |
| 52-Week High | 2,705 |
| 52-Week Low | 1,909.7 |
| Moving Average 50 Days | 2,402.51 |
| Moving Average 200 Days | 2,331.16 |
| Average Volume | 568,366 |
| Shares Outstanding | 413.05M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |